ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,481,000 | +78.2% | 8,606 | +30.0% | 0.01% | +60.0% |
| Q2 2021 | $831,000 | +9.1% | 6,621 | +17.8% | 0.01% | +25.0% |
| Q1 2021 | $762,000 | +30.0% | 5,619 | +22.7% | 0.00% | 0.0% |
| Q4 2020 | $586,000 | +98.0% | 4,579 | +74.1% | 0.00% | +100.0% |
| Q3 2020 | $296,000 | +19.8% | 2,630 | -39.1% | 0.00% | 0.0% |
| Q3 2018 | $247,000 | -31.0% | 4,317 | -41.5% | 0.00% | 0.0% |
| Q2 2018 | $358,000 | +7.8% | 7,376 | -13.2% | 0.00% | 0.0% |
| Q1 2018 | $332,000 | -37.9% | 8,494 | -32.6% | 0.00% | -50.0% |
| Q4 2017 | $535,000 | -73.8% | 12,606 | -84.2% | 0.00% | -73.3% |
| Q4 2016 | $2,039,000 | +1468.5% | 79,912 | +1993.6% | 0.02% | +1400.0% |
| Q2 2016 | $130,000 | +47.7% | 3,817 | +14.3% | 0.00% | 0.0% |
| Q1 2016 | $88,000 | -9.3% | 3,340 | +67.2% | 0.00% | 0.0% |
| Q4 2015 | $97,000 | +49.2% | 1,998 | -23.7% | 0.00% | 0.0% |
| Q3 2015 | $65,000 | +261.1% | 2,619 | +364.4% | 0.00% | – |
| Q2 2015 | $18,000 | +5.9% | 564 | +28.2% | 0.00% | – |
| Q1 2015 | $17,000 | -98.0% | 440 | -98.0% | 0.00% | -100.0% |
| Q4 2014 | $868,000 | +5325.0% | 22,276 | +4167.4% | 0.01% | – |
| Q3 2014 | $16,000 | -95.8% | 522 | -95.4% | 0.00% | -100.0% |
| Q2 2014 | $382,000 | – | 11,251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 2 | $358 | 0.00% |